These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6336282)

  • 21. [Spiroergometry in patients with pulmonary hypertension by lung fibrosis, primary pulmonary hypertension, chronic thrombolic pulmonary hypertension and cystic fibrosis].
    Englisch-Fritz C
    Pneumologie; 2004 Oct; 58(10):739-40. PubMed ID: 15476113
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemodynamic evaluation of nifedipine in primary pulmonary hypertension--short and long term effects].
    Yamaguchi S; Tsuiki K; Hayasaka M; Oguma M; Ohta I; Kaminishi T; Sukekawa H; Kanaya T; Yasui S
    Kokyu To Junkan; 1986 Feb; 34(2):171-6. PubMed ID: 3704359
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of calcium antagonists in the treatment of patients with chronic nonspecific lung diseases].
    Vereshchagina GN; Vasilenko GP; Kuleshova TV
    Klin Med (Mosk); 1988 Mar; 66(3):41-4. PubMed ID: 3392921
    [No Abstract]   [Full Text] [Related]  

  • 24. One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease.
    Vestri R; Philip-Joet F; Surpas P; Arnaud A; Saadjian A
    Respiration; 1988; 54(2):139-44. PubMed ID: 3068741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effects of diltiazem on pulmonary hemodynamics and oxygenation in copd induced pulmonary hypertension].
    Fang B; Wang C; Dai H
    Zhonghua Yi Xue Za Zhi; 1998 Oct; 78(10):779-81. PubMed ID: 11038835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of oxygen therapy on pulmonary arterial hypertension in chronic obstructive lung disease.
    Zielinski J
    G Ital Cardiol; 1984; 14 Suppl 1():61-3. PubMed ID: 6398782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of mixed venous blood PO2 on the pulmonary arterial pressure in chronic obstructive pulmonary disease (COPD): correlations in 128 patients].
    Geraads A; Pirotte C; Rigaud D; Ligeonnet D; Paramelle B
    Poumon Coeur; 1983; 39(5):221-7. PubMed ID: 6657548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydralazine in pulmonary hypertension.
    N Engl J Med; 1982 Nov; 307(19):1214-6. PubMed ID: 7121553
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary pulmonary hypertension, nifedipine, and hypoxemia.
    Krol RC; Evans AT; Albright DP; Reilly JM
    Ann Intern Med; 1984 Jan; 100(1):163. PubMed ID: 6691651
    [No Abstract]   [Full Text] [Related]  

  • 31. [Systemic arterial hypertension and lung disease].
    Mukharliamov NM
    Ter Arkh; 1983; 55(1):54-7. PubMed ID: 6836527
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary pulmonary hypertension. Lung function tests].
    Kummer F
    Wien Z Inn Med; 1969; 50(10):484-6. PubMed ID: 5406760
    [No Abstract]   [Full Text] [Related]  

  • 33. [Heart pathology of extracardiac origin. IV. Pulmonary hypertension in chronic respiratory diseases].
    Barberà JA
    Rev Esp Cardiol; 1998 Jan; 51(1):56-68. PubMed ID: 9522610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acute effects of cilazapril on pulmonary function tests and arterial blood gas changes in patients with pulmonary hypertension.
    Tavli T; Sekuri C; Goktalay T; Uyanik BS; Ari Z
    Int J Clin Pharmacol Res; 2003; 23(2-3):53-9. PubMed ID: 15018019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Precapillary arterial pulmonary hypertension and hemorrheologico-coagulation changes].
    Micillo E; Dericoloso A; Tranchese D; Crispano G; Soverina P; Caputi M
    Arch Monaldi Mal Torace; 1987; 42(6):585-91. PubMed ID: 3508372
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute effects of nifedipine administration in pulmonary haemodynamics and oxygen delivery during exercise in patients with chronic obstructive pulmonary disease: implication of the angiotensin-converting enzyme gene polymorphisms.
    Kanazawa H; Tateishi Y; Yoshikawa J
    Clin Physiol Funct Imaging; 2004 Jul; 24(4):224-8. PubMed ID: 15233837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Symptomatic hypertension in chronic obstructive diseases of the lungs (based on data from the Armenian SSR)].
    Eramian SG; Airapetian TsS
    Klin Med (Mosk); 1972 Dec; 50(12):116-20. PubMed ID: 4660494
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodynamic effects of nifedipine in pulmonary hypertension.
    Klugmann S; Salvi A; Fioretti P; Camerini F
    G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of nifedipine and captopril in children with pulmonary hypertension due to bronchopneumonia.
    Uner A; Dogan M; Demirtas M; Açikgöz M; Temel H; Kaya A; Caksen H
    J Trop Pediatr; 2008 Oct; 54(5):294-9. PubMed ID: 18304952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
    Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
    Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.